Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPredictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases
Annals of Thoracic Surgery, 07/01/09
Lee FC et al. - In a study to analyze factors predicting long-term survival in patients with esophageal carcinoma and celiac, cervical, or other nonregional nodal metastases, it apears that surgical resection for pts with esophageal cancer associated with nonregional nodal metastases results in 25% survival at 5 yrs. Squamous histology, earlier T status, and perioperative chemotherapy are independent positive predictors of long-term survival.
Methods- A retrospective review was conducted of a prospective database over a 20-yr period to identify pts with resected esophageal carcinoma with nonregional lymph node metastases.
- Medical records were reviewed and risk factors were analyzed.
- 67 pts underwent esophagectomy for M1a or M1b disease.
- Esophagectomy was transthoracic in 62 pts and transhiatal in 5.
- Median number of lymph nodes harvested was 36.
- Sites of nodal metastases were the following: recurrent nodal chain in 42 pts, celiac in 20, both recurrent and celiac in 4, and paratracheal in 1.
- Median length of follow-up was 66 mos; 5-yr overall survival (OS) for the cohort was 25%; 5-yr OS was significantly higher with earlier T-status.
- 13 pts who had nonregional nodal metastases without involvement of regional nodes (pN0) had a significant improvement in 5-yr survival (67% vs 15%).
- Pts with squamous cell carcinomas had higher 5-yr survival vs those with adenocarcinomas (42% vs 14%).
- Pts treated with induction chemotherapy had prolonged 5-yr survival (41%) vs those treated with adjuvant chemotherapy (11%) or no therapy (20%).
- Multivariate analysis demonstrated that chemotherapy treatment, squamous cell type, and early T stage (pT1/T2) are significant positive predictors of survival.
Related Articles
The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period
BMC Cancer, 11/02/09
Relevance Score: 67%
Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy
Head & Neck, 11/06/09
Relevance Score: 66%
A Critical Appraisal of Circumferential Resection Margins in Esophageal Carcinoma
Annals of Surgical Oncology, 11/23/09
Relevance Score: 65%
Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan
Cancer Causes and Control, 11/04/09
Relevance Score: 65%
Long-term survivors of esophageal cancer: Disease-specific quality of life, general health and complications
Journal of Surgical Oncology, 11/02/09
Relevance Score: 65%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
The Journal of Pathology, 12/11/09
Extracapsular lymph node spread
Cancer, 12/11/09
Variations in gastric cancer care
Cancer, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor